Keywords
lost to follow-up
Zinder
How to Cite
Abstract
Introduction :
Loss to follow-up or loss of sight, in addition to spreading tuberculosis, promotes the emergence of multidrug-resistant tuberculosis. The objective of this study was to determine the factors associated with loss to follow-up in urban settings in Zinder region.
Materials and methods :
This was a cross-sectional, descriptive study using data from patients treated for tuberculosis and reported lost to follow-up in diagnostic centers in the Zinder region. Data analysis was done using Epi Info version 7 software.
Results :
The prevalence of lost to follow-up was 10.5%. The average annual inclusion rate was 28 patients, i.e. 84 patients over 3 years. 77 patients were male and 7 female. 68% of the patients were not in school compared to 32%. Single patients represented 61% of the patients compared to 31% of single patient. The average age of the patients was 35 years. 54 patients were tested for HIV with the results of 4 patients positive for HIV. 93% of the patients were new cases of tuberculosis. 89% were cases of pulmonary tuberculosis. We identified 6 causes of loss of sight including distance from the treatment center, denial of the disease, lack of improvement, use of traditional medicine and feeling cured.
Conclusion :
Better communication with the patient about the disease and collaboration between practitioners can contribute to significantly reduce the scourge of lost to follow-up.
References
1. Programme National de lutte contre la Tuberculose (PNLT) du Niger. Guide technique national de lutte contre la tuberculose. 3ème Edition 2017 : 58p
2. Organisation Mondiale de la Santé. Global tuberculosis report 2022, 68p. https://www.who.int/teams/globaltuberculosis-programme/tb-reports/globaltuberculosis-report-2022
3. OMS | Stratégie de l’OMS pour mettre fin à la tuberculose d’ici 2035. WHO [Epub ahead of print]. consulté le 10 04 2023 à 10h00
4. https://apps.who.int/iris/bitstream/handle/10665 /66142/WHO_CDS_CPC_TB_99.270_fre.pdf?se quence=1&isAllowed=y consulté le 10 04 2023 à 13H00.
5. Attinsounon CA, Fortes-Déguénonvo L, Diop SA, Cissoko Y, Kpangon AA, Manga NM et al. Devenir des patients perdus de vue sous traitement antituberculeux à Dakar (Sénégal). Rev Pneumol Trop, 2014 ; 21: 30-35
6. Balkissou AD, Poka-Mayap V, Kuaban A, Mangoh TL, Touoyem LJ, Djao KA et al. Incidence and Factors Associated with Default Among Adults Treated for Tuberculosis in Two Regions of Cameroon. Health Sci. Dis. 2021 ; 22 (10) : 74-79
7. Bemba E.L.P, Bopaka R .G,Ossibi-Ibara R, Toungou SN, Ossale-Abacka BK, OkembaOkombi FH , Mboussa J. Facteurs prédictifs associés au statut de perdu de vue au cours du traitement antituberculeux à Brazzaville. Revue de Pneumologie clinique 2017 ; 73 : 81-89
8. Abdoulaye O, Yaou MM, Yacouba A, Doutchi M, Harouna ZH, Harouna Amadou ML et al. Prévalence et facteurs prédictifs de la résistance aux antituberculeux de deuxième ligne chez les patients tuberculeux résistants à la rifampicine au Niger. Rev Mali Infect Microbiol 2021 ; 16 (3) : 88-92
9. Institut National de la Statistique (INS) et ICF International. 2013. Enquête Démographique et de Santé et à Indicateurs Multiples du Niger 2012 : Rapport de synthèse. Calverton, Maryland, USA : INS et ICF International.
10. Van Hest R, Ködmön C, Verver S, Erkens CGM, Straetemans M, Manissero D et al. Tuberculosis treatment outcome monitoring in European Union countries: systematic review. Eur Respir J 2013; 41: 635 –43.
11. Sengul A, Akturk U A, Aydemir Y, Kaya N, Kocak N D, Tasolar F T. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005–2011. J Infect Dev Ctries 2015; 9(08): 821.
12. Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. Int J Infect Dis 2017; 54: 95–102.
13. Toung Mvé M, Bisvigou U, Diop Barry NC, Ondo CE, Nkoghe D. Les causes d’abandon et les motivations d’une reprise de traitement au Centre antituberculeux de Libreville (Gabon). Cahiers Santé 2010 ; 20 (1): 31 –3 4.
14. Mutaz A A, Talal E M, Mohammed A S, Heitham M A, Anas E A, Fatima K A. Factors associated with default from treatment among tuberculosis patients in Kassala State, Sudan. J. Public Health Epidemiol, 2015 ; 7(6) : 183-188.
15. Habibi B, Atmane A, Hammi S, Bourkadi J, Marc K, Soualhi M et al. Les facteurs de risque de l’abandon du traitement anti-bacillaire chez les patients atteints de tuberculose pulmonaire à microscopie positive (TPM+). Rev Mal Respir 2016 ; 33 : 42-43
16. Toung Mvé M, Bisvigou U, Diop Barry NC, Ondo CE, Nkoghe D. Les causes d’abandon et les motivations d’une reprise de traitement au Centre antituberculeux de Libreville (Gabon). Cahiers Santé 2010 ; 20 (1): 31 – 4
17. M’Boussa J, Martins H, Adicolle-Metoul JM, Loubaki F. L’influence des facteurs socioculturels sur les abandons du traitement de la tuberculose pulmonaire. Méd Afr Noire 1999 ; 46 (10) : 458 – 65.
18. Hassani L. Les facteurs impliqués dans l’abandon du traitement anti-bacillaire chez les patients atteints de tuberculose pulmonaire à microscopie positive. Cas des préfectures Ain Chock – Hay Hassani – Nouaceur. Région du Grand Casablanca. Mémoire de fin d’étude, INAS, Maroc, Juillet 2010 ; 86p.
19. Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, et al. Tuberculosis treatment adherence and fatality in Spain. Respir Res 2009 ; 10 : 121.
20. Zaghba N, Bakhatar A, Yassine N, Bellekhal N, Bahlaoui N. Abandon du traitement antibacillaire. Rev Mal Respir 2009; 26 : 136 – 40.
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 H Issa, M Doutchi, M Goni Allassane, M Gagara Ai, A Amoussa, S Alphazazi, A Adambounou Tété, D Maizoumbou, S Adjoh Komi